Company
Genomics company helping Australians make informed health decisions in areas such as carrier screening and genetic risk assessment.
Every investor coverage indicates participated in a round Eugene raised.
Companies Eugene acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Eugene. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Funding roundup covering six Australian-linked startups: Superpower's US$30m Series A, WeMoney's $12m Series A plus debt facility, InsightWise's $1m pre-seed, and Bupa's first venture investments in three health startups.
Five Australian digital health startups received a combined $3.25 million in stage-two grant funding from the Medical Research Future Fund, facilitated by ANDHealth.
Profile of ALIAVIA, the venture fund Marisa Warren and Kate Vale started to back women founders across Australia and the US, its Australian backers, and its portfolio companies Eugene, Loupe, HowToo and Othelia AI.
Profile of ALIAVIA, the venture fund Marisa Warren and Kate Vale run from California to back women founders across Australian and US markets; also covers its backers, early investments, and Warren's ELEVACAO program.
Female-led VC ALIAVIA has closed a US$8.7 million fund, backed by Robyn Denholm, Carol Schwartz, Cynthia Scott, Tattarang and Dom Pym, to invest in female-founded startups across Australia and the US.
ALIAVIA Ventures has closed its debut fund at A$13.5 million. The US-based firm backs female founders bridging Australian and US markets; backers include Carol Schwartz, Tattarang, the Denholms, Euphemia, Dom Pym and Cynthia Scott.